COVID-19 and the Chemical Senses: Supporting Players Take Center Stage

  • Keiland W. Cooper (First Author)
  • , David H. Brann (Co-Author)
  • , Michael C. Farruggia (Co-Author)
  • , Surabhi Bhutani (Co-Author)
  • , Robert Pellegrino (Co-Author)
  • , Tatsuya Tsukahara (Co-Author)
  • , Caleb Weinreb (Co-Author)
  • , Paule V. Joseph (Co-Author)
  • , Eric D. Larson (Co-Author)
  • , Valentina Parma (Co-Author)
  • , Mark W. Albers (Co-Author)
  • , Linda A. Barlow* (Co-Author)
  • , Sandeep Robert Datta* (Co-Author)
  • , Antonella Di Pizio* (Last Author)
  • *Corresponding author for this work

Research output: Contribution to journalReview article / Perspectivespeer-review

250 Scopus citations

Abstract

The main neurological manifestation of COVID-19 is loss of smell or taste. The high incidence of smell loss without significant rhinorrhea or nasal congestion suggests that SARS-CoV-2 targets the chemical senses through mechanisms distinct from those used by endemic coronaviruses or other common cold-causing agents. Here we review recently developed hypotheses about how SARS-CoV-2 might alter the cells and circuits involved in chemosensory processing and thereby change perception. Given our limited understanding of SARS-CoV-2 pathogenesis, we propose future experiments to elucidate disease mechanisms and highlight the relevance of this ongoing work to understanding how the virus might alter brain function more broadly.

Original languageEnglish
Pages (from-to)219-233
Number of pages15
JournalNeuron
Volume107
Issue number2
DOIs
StatePublished - 22 Jul 2020

Fingerprint

Dive into the research topics of 'COVID-19 and the Chemical Senses: Supporting Players Take Center Stage'. Together they form a unique fingerprint.

Cite this